Oventus Medical Limited (ASX:OVN)

8.9¢

right-arrow Created with Sketch. -0.001 (-1.11%)
MCAP $21.51M
Last trade 15.52pm 03/12/2021 20mins delayed

Latest Announcements

24/11/2021OVNOventus Medical Limited
117
MCap
19/11/2021OVNOventus Medical Limited
18/11/2021OVNOventus Medical Limited
18/11/2021 Price SensitivePSOVNOventus Medical Limited
190
MCap
18/11/2021 Price SensitivePSOVNOventus Medical Limited
09/11/2021OVNOventus Medical Limited
09/11/2021OVNOventus Medical Limited
09/11/2021OVNOventus Medical Limited

Company Overview

Oventus Medical Limited is an Australia-based medical device company with technology for the treatment of obstructive sleep apnea (OSA) and snoring. The Company has two operating segments, which include Australia and North America. The Company’s O2Vent devices are designed for any patient that suffers from nasal congestion, obstruction and mouth breathing. Its O2Vent Optima devices allow airflow to the back of the mouth while maintaining an oral seal and stable jaw position, which avoids obstructions from the nose, soft palate and tongue. The Company’s ExVent is a valve accessory that fits into the open airway of the O2Vent Optima device to augment traditional oral appliance therapy by stabilizing the airway. The ExVent valve contains air vents that open fully on inhalation for unobstructed airflow. The O2Vent Optima is an alternative to continuous positive airway pressure (CPAP) for the treatment of obstructive sleep apnea.

OVN in the news

Sleep apnoea specialist Oventus Medical (OVN) has received firm commitments to undertake…
Oventus Medical (OVN) has signed new contracts with U.S.-based national durable medical…
Oventus (OVN) has raised $2 million through a share purchase plan, after…

Search Previous Announcements